Aurelia Alañón Molina
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aurelia Alañón Molina has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
- José Antonio Murillo Pulgarín
Department of Analytical Chemistry and Foods Technology, University of Castilla-La Mancha, 13071 Ciudad Real, Spain
11 shared publications Pablo Fernández López
University of Castilla La Mancha
11 shared publicationsJosé Antonio Murillo Pulgarín
Department of Analytical Chemistry and Food Technology, University of Castilla-La Mancha, Ciudad Real, Spain
7 shared publicationsJ. A. Murillo Pulgarín
University Castilla-La Mancha
6 shared publicationsJosé A. Murillo Pulgarín
Department of Analytical Chemistry and Food Technology, University of Castilla-La Mancha, 13071 Ciudad Real, Spain
5 shared publicationsN. Boras
University Castilla-La Mancha
5 shared publications
Latest Publications
- 11 June 2021
- Published by Pleiades Publishing Ltd in Journal of Analytical Chemistry
- Vol. 76 (6) , 733-741
Use of Total Fluorescence Spectroscopy for the Highly Sensitive Simultaneous Determination of Fluoroquinolones in Rabbit Plasma
A method for the quantification of a mixture of fluorescent antibiotics with broad, highly overlapped excitation and emission spectra is proposed. The method enables the simultaneous determination of sarafloxacin, flumequine and ofloxacin by using the fluorescence excitation-emission matrix and performing two different scans, namely, a linear variable angle synchronous fluorimetry scan at 15.6° and an emission scan at λexc of 320 nm. This ensures complete resolution of the mixture without the need for a separation technique. Various factors influencing the fluorescence intensity were assessed in order to maximize the sensitivity and obtain an adequate selectivity. The method was successfully used to determine the analytes in pharmaceuticals and rabbit plasma. The results obtained compared favorably with those provided by HPLC.
- 11 June 2021
- Published by Pleiades Publishing Ltd in Journal of Analytical Chemistry
- Vol. 76 (6) , 733-741
Use of Total Fluorescence Spectroscopy for the Highly Sensitive Simultaneous Determination of Fluoroquinolones in Rabbit Plasma
A method for the quantification of a mixture of fluorescent antibiotics with broad, highly overlapped excitation and emission spectra is proposed. The method enables the simultaneous determination of sarafloxacin, flumequine and ofloxacin by using the fluorescence excitation-emission matrix and performing two different scans, namely, a linear variable angle synchronous fluorimetry scan at 15.6° and an emission scan at λexc of 320 nm. This ensures complete resolution of the mixture without the need for a separation technique. Various factors influencing the fluorescence intensity were assessed in order to maximize the sensitivity and obtain an adequate selectivity. The method was successfully used to determine the analytes in pharmaceuticals and rabbit plasma. The results obtained compared favorably with those provided by HPLC.
- 8 December 2019
- Published by Wiley in Journal of Raman Spectroscopy
- Vol. 51 (3) , 406-413
A sensitive resonance Rayleigh scattering sensor for dopamine in urine using upconversion nanoparticles
A highly sensitive resonance light scattering method for detecting dopamine in urine was developed by using a novel probe based on lanthanide‐doped upconversion nanoparticles (UCNPs) linked to dopamine–quinone (DQ) by hydrogen bonding and electrostatic interactions. Adding dopamine to a solution containing UCNPs decreases their size and the intensity of their resonance light scattering signals. Based on the decrease, dopamine can be determined in Tris–HCl buffer and in urine samples spiked with analyte concentrations over the range 0–300 μM with a limit of detection of 1.62 μM. As‐prepared UD can thus provide an effective platform for biosensor development, drug discovery, and rapid diagnosis of Parkinson's and Alzheimer's disease, among other medical conditions.
- 8 December 2019
- Published by Wiley in Journal of Raman Spectroscopy
- Vol. 51 (3) , 406-413
A sensitive resonance Rayleigh scattering sensor for dopamine in urine using upconversion nanoparticles
A highly sensitive resonance light scattering method for detecting dopamine in urine was developed by using a novel probe based on lanthanide‐doped upconversion nanoparticles (UCNPs) linked to dopamine–quinone (DQ) by hydrogen bonding and electrostatic interactions. Adding dopamine to a solution containing UCNPs decreases their size and the intensity of their resonance light scattering signals. Based on the decrease, dopamine can be determined in Tris–HCl buffer and in urine samples spiked with analyte concentrations over the range 0–300 μM with a limit of detection of 1.62 μM. As‐prepared UD can thus provide an effective platform for biosensor development, drug discovery, and rapid diagnosis of Parkinson's and Alzheimer's disease, among other medical conditions.
- 23 July 2014
- Published by Pleiades Publishing Ltd in Journal of Analytical Chemistry
- Vol. 69 (8) , 735-740
Direct determination of antibacterial norfloxacin in urine by isopotential fluorimetry
A novel and simple method is presented for the determination of norfloxacin in human urine by matrix isopotential synchronous fluorescence spectrometry (MISF). This method is useful for the determination of compounds in samples with unknown background fluorescence, such as norfloxacin in urine, without the need for tedious sample pre-treatment. The method was performed in ethanol-water medium (10% v/v), at an apparent pH of 4.8 provided by adding sodium acetate-acetic acid buffer solution. In the determination of norfloxacin in urine the fluorescent intensity varied linearly with its concentration from 20 to 200 ng/mL. An exhaustive statistical analysis has been developed to all calibration graphs, this treatment includes robust regression such as least median of squares, which also detects outliers and leverage points. The overall least-squares regression has been applied to find the more exact straight line that fits the experimental data. The error propagation has been considered to calculate the detection limit and the repeatability of the method. The method shows very low detection limits with acceptable recoveries and precisions. The applicability of the proposed method was illustrated in the determination of norfloxacin in human urine sample without sample pre-treatment.
- 23 July 2014
- Published by Pleiades Publishing Ltd in Journal of Analytical Chemistry
- Vol. 69 (8) , 735-740
Direct determination of antibacterial norfloxacin in urine by isopotential fluorimetry
A novel and simple method is presented for the determination of norfloxacin in human urine by matrix isopotential synchronous fluorescence spectrometry (MISF). This method is useful for the determination of compounds in samples with unknown background fluorescence, such as norfloxacin in urine, without the need for tedious sample pre-treatment. The method was performed in ethanol-water medium (10% v/v), at an apparent pH of 4.8 provided by adding sodium acetate-acetic acid buffer solution. In the determination of norfloxacin in urine the fluorescent intensity varied linearly with its concentration from 20 to 200 ng/mL. An exhaustive statistical analysis has been developed to all calibration graphs, this treatment includes robust regression such as least median of squares, which also detects outliers and leverage points. The overall least-squares regression has been applied to find the more exact straight line that fits the experimental data. The error propagation has been considered to calculate the detection limit and the repeatability of the method. The method shows very low detection limits with acceptable recoveries and precisions. The applicability of the proposed method was illustrated in the determination of norfloxacin in human urine sample without sample pre-treatment.
- 1 July 2014
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 128, 82-90
Application of time-resolved fluorescence to the determination of metabolites
- 1 July 2014
- Published by Elsevier in Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy
- Vol. 128, 82-90
Application of time-resolved fluorescence to the determination of metabolites
- 5 March 2014
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 6 (10) , 3329-3334
Simple and rapid determination of salsalate in pharmaceutical preparations by chemiluminescence
The chemiluminescent behaviour of salsalate when reacted with a common oxidant, potassium permanganate in different acidic media, using the stopped-flow technique in a continuous-flow system is described. The optimum chemical conditions for the chemiluminescence emission were investigated. A weak CL emission was found to be emitted during the oxidation of this drug with potassium permanganate in an acidic solution. The effect of common emission enhancers, organized systems and metals ions was investigated. The parameters selected were 4.0 mol L−1 sulfuric acid, 1.5 mmol L−1 permanganate and 0.25 mol L−1 formaldehyde. Three quantitative parameters adjustable via software settings, one of them typically a kinetic parameter, such as the rate of the light-development reaction, and the other conventional parameters, such as maximum emission intensity and total emission area, were used to obtain linear calibration graphs with each measurement parameter. The calibration graphs were linear for the concentration range from 25 to 250 ng mL−1. The detection limits, according to Clayton et al., ranged from 2.85 to 15.19 ng mL−1. The present chemiluminescence procedures were applied to the determination of salsalate in a Spanish pharmaceutical formulation, with excellent recovery, as the determination is free from interference from common excipients present in the formulation.
- 5 March 2014
- Published by Royal Society of Chemistry (RSC) in Analytical Methods
- Vol. 6 (10) , 3329-3334
Simple and rapid determination of salsalate in pharmaceutical preparations by chemiluminescence
The chemiluminescent behaviour of salsalate when reacted with a common oxidant, potassium permanganate in different acidic media, using the stopped-flow technique in a continuous-flow system is described. The optimum chemical conditions for the chemiluminescence emission were investigated. A weak CL emission was found to be emitted during the oxidation of this drug with potassium permanganate in an acidic solution. The effect of common emission enhancers, organized systems and metals ions was investigated. The parameters selected were 4.0 mol L−1 sulfuric acid, 1.5 mmol L−1 permanganate and 0.25 mol L−1 formaldehyde. Three quantitative parameters adjustable via software settings, one of them typically a kinetic parameter, such as the rate of the light-development reaction, and the other conventional parameters, such as maximum emission intensity and total emission area, were used to obtain linear calibration graphs with each measurement parameter. The calibration graphs were linear for the concentration range from 25 to 250 ng mL−1. The detection limits, according to Clayton et al., ranged from 2.85 to 15.19 ng mL−1. The present chemiluminescence procedures were applied to the determination of salsalate in a Spanish pharmaceutical formulation, with excellent recovery, as the determination is free from interference from common excipients present in the formulation.
- 1 September 2013
- Published by SAGE Publications in Applied Spectroscopy
- Vol. 67 (9) , 1029-1035
Development of a Spectrofluorimetric Method for the Determination of Ofloxacin in Urine
A simple, accurate, rapid, and sensitive spectrofluorimetric method for the determination of ofloxacin in urine was developed by means of first derivative matrix isopotential synchronous fluorescence spectrometry (MISF). The calibration curve was found to be linear in the concentration range 40–320 ng/mL. The method allows the determination of compound in samples with unknown background fluorescence without the need for tedious pre-separation. Synchronous scans are performed along a trajectory that connects points of identical intensity in a three-dimensional fluorescence spectrum. The unknown analytical signal of the urine is suppressed from the MISF spectrum by calculating its first derivative at λex = 319.2 and λem = 465 nm. In order to ensure maximum sensitivity and adequate selectivity, the experimental variables affecting fluorescence intensity were studied in the ofloxacin band centered at λex = 333 and λem = 460 nm. As result, the determination was performed in a water medium at pH 7.2, adjusted by using sodium dihydrogen phosphate as a buffer solution. Calibration graphs were subjected to a comprehensive statistical analysis. The detection limit according to Long and Winefordner was 8.4 ng/mL, and the detection limit proposed by Clayton was 13.9 ng/mL.
- 1 September 2013
- Published by SAGE Publications in Applied Spectroscopy
- Vol. 67 (9) , 1029-1035
Development of a Spectrofluorimetric Method for the Determination of Ofloxacin in Urine
A simple, accurate, rapid, and sensitive spectrofluorimetric method for the determination of ofloxacin in urine was developed by means of first derivative matrix isopotential synchronous fluorescence spectrometry (MISF). The calibration curve was found to be linear in the concentration range 40–320 ng/mL. The method allows the determination of compound in samples with unknown background fluorescence without the need for tedious pre-separation. Synchronous scans are performed along a trajectory that connects points of identical intensity in a three-dimensional fluorescence spectrum. The unknown analytical signal of the urine is suppressed from the MISF spectrum by calculating its first derivative at λex = 319.2 and λem = 465 nm. In order to ensure maximum sensitivity and adequate selectivity, the experimental variables affecting fluorescence intensity were studied in the ofloxacin band centered at λex = 333 and λem = 460 nm. As result, the determination was performed in a water medium at pH 7.2, adjusted by using sodium dihydrogen phosphate as a buffer solution. Calibration graphs were subjected to a comprehensive statistical analysis. The detection limit according to Long and Winefordner was 8.4 ng/mL, and the detection limit proposed by Clayton was 13.9 ng/mL.
- 1 April 2013
- Published by SAGE Publications in Applied Spectroscopy
- Vol. 67 (4) , 371-378
Simultaneous Determination of Doxycycline and Chlortetracycline in Real Samples by Europium-Sensitized Luminescence
A simple luminescent methodology for the simultaneous determination of doxycycline and chlortetracycline in pharmaceutical preparations and human urine is proposed. Since the native fluorescence of both analytes is negligible, this method takes advantage of the lanthanide-sensitized luminescence, which provides increased sensitivity. Due to the strong overlapping between the luminescence spectra of both europium complexes, the use of luminescence decay curves to resolve mixtures of the analytes is proposed, particularly as these curves are more selective. A factorial design, with three levels per factor, coupled to a central composite design was selected to obtain a calibration matrix of 13 standards plus one blank sample, which were processed with a partial least-squares analysis. In order to assess the effectiveness of the proposed method, a prediction set of 10 synthetic samples was analyzed, and recovery percentages between 95 and 104% were obtained. Limits of detection, calculated by means of a new criterion, were 3.27 and 1.06 μg L−1 for doxycycline and chlortetracycline, respectively. The method was tested in three different pharmaceutical preparations containing the analytes, with average recovery percentages of 99.4 ± 1.8 for doxycycline and 100.5 ± 2.1 for chlortetracycline. Moreover, a central composite design was also developed to obtain a calibration matrix that made feasible the simultaneous determination of both tetracyclines in human urine samples. In this case, average recovery percentages were 98.0 ± 4.4 and 97.8 ± 4.6 for doxycycline and chlortetracycline, respectively. No extraction method or prior separation of the analytes was needed.
- 1 April 2013
- Published by SAGE Publications in Applied Spectroscopy
- Vol. 67 (4) , 371-378
Simultaneous Determination of Doxycycline and Chlortetracycline in Real Samples by Europium-Sensitized Luminescence
A simple luminescent methodology for the simultaneous determination of doxycycline and chlortetracycline in pharmaceutical preparations and human urine is proposed. Since the native fluorescence of both analytes is negligible, this method takes advantage of the lanthanide-sensitized luminescence, which provides increased sensitivity. Due to the strong overlapping between the luminescence spectra of both europium complexes, the use of luminescence decay curves to resolve mixtures of the analytes is proposed, particularly as these curves are more selective. A factorial design, with three levels per factor, coupled to a central composite design was selected to obtain a calibration matrix of 13 standards plus one blank sample, which were processed with a partial least-squares analysis. In order to assess the effectiveness of the proposed method, a prediction set of 10 synthetic samples was analyzed, and recovery percentages between 95 and 104% were obtained. Limits of detection, calculated by means of a new criterion, were 3.27 and 1.06 μg L−1 for doxycycline and chlortetracycline, respectively. The method was tested in three different pharmaceutical preparations containing the analytes, with average recovery percentages of 99.4 ± 1.8 for doxycycline and 100.5 ± 2.1 for chlortetracycline. Moreover, a central composite design was also developed to obtain a calibration matrix that made feasible the simultaneous determination of both tetracyclines in human urine samples. In this case, average recovery percentages were 98.0 ± 4.4 and 97.8 ± 4.6 for doxycycline and chlortetracycline, respectively. No extraction method or prior separation of the analytes was needed.
- 5 March 2013
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 61 (11) , 2655-2660
Direct Determination of Danofloxacin and Flumequine in Milk by Use of Fluorescence Spectrometry in Combination with Partial Least-Squares Calibration
A new method for the simultaneous determination of danofloxacin and flumequine in milk samples was developed by using the nonlinear variable-angle synchronous fluorescence technique to acquire data and a partial least-squares chemometric algorithm to process them. A calibration set of standard samples was designed by combination of a factorial design with two levels per factor and a central star design. Whey was used as the third component of the calibration matrix. In order to assess the goodness of the proposed method, a prediction set of 11 synthetic samples was analyzed, obtaining recovery percentages between 96.1% and 104.0%. Limits of detection, calculated by means of a new criterion, were 0.90 and 12.4 ng mL–1 for danofloxacin and flumequine, respectively. Finally, the simultaneous determination of both fluoroquinoles in milk samples containing the analytes was successfully carried out, obtaining an average recovery percentage of 99.3 ± 4.4 for danofloxacin and 100.7 ± 4.4.
- 5 March 2013
- Published by American Chemical Society (ACS) in Journal of Agricultural and Food Chemistry
- Vol. 61 (11) , 2655-2660
Direct Determination of Danofloxacin and Flumequine in Milk by Use of Fluorescence Spectrometry in Combination with Partial Least-Squares Calibration
A new method for the simultaneous determination of danofloxacin and flumequine in milk samples was developed by using the nonlinear variable-angle synchronous fluorescence technique to acquire data and a partial least-squares chemometric algorithm to process them. A calibration set of standard samples was designed by combination of a factorial design with two levels per factor and a central star design. Whey was used as the third component of the calibration matrix. In order to assess the goodness of the proposed method, a prediction set of 11 synthetic samples was analyzed, obtaining recovery percentages between 96.1% and 104.0%. Limits of detection, calculated by means of a new criterion, were 0.90 and 12.4 ng mL–1 for danofloxacin and flumequine, respectively. Finally, the simultaneous determination of both fluoroquinoles in milk samples containing the analytes was successfully carried out, obtaining an average recovery percentage of 99.3 ± 4.4 for danofloxacin and 100.7 ± 4.4.